Status:
COMPLETED
Lipid-Lowering Effect and Hypotensive Effect of Shanzha Fruit Drink in Patients
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Hyperlipidemia
Hypertension
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
This is a single-center, randomized, double-blind, placebo-controlled, cross-over study. Subjects who meet the inclusion/exclusion criteria will be randomly and alternatively assigned to receive Shanz...
Eligibility Criteria
Inclusion
- • Total Cholesterol between 200-300 mg/dl (5.2-7.8 mmol/l).
- Mean plasma triglyceride \>= 4.5 mmol/l.
- Diastolic blood pressure 95-100 mm Hg and/or Systolic blood pressure 130-150 mm Hg.
- Be able to give written informed consent prior to study start and comply with study requirements.
Exclusion
- • Total Cholesterol between 200-300 mg/dl (5.2-7.8 mmol/l).
- Mean plasma triglyceride \< 4.5 mmol/l.
- Diastolic blood pressure 95-100 mm Hg and/or Systolic blood pressure 130-150 mm Hg.
- Be able to give written informed consent prior to study start and comply with study requirements.
Key Trial Info
Start Date :
January 2 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 30 2020
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT04672278
Start Date
January 2 2019
End Date
October 30 2020
Last Update
April 23 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Chinese University of Hong Kong
Hong Kong, Hong Kong